Evidence map›Paper›PMID 39911684›Full record

ArticleAdvances in ophthalmology practice and research

A novel

Wei Wu, Ying Zhang, Jingjie Xu, Hua Jiang, Xiangjun Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in ophthalmology practice and research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei WuEye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Ying ZhangEye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Jingjie XuEye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Hua JiangDepartment of Otolaryngology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Xiangjun ChenEye Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Retinitis pigmentosa (RP) is a genetically and clinically heterogeneous group of hereditary degenerative disorders affecting approximately one in every 4000 people worldwide. Abnormalities in the retina's photoreceptors can cause night blindness or even complete vision loss. Retinitis Pigmentosa 1 (RP1), also known as the oxygen-regulated protein-1, is a microtubule-associated protein (MAP) that organizes the outer segment of the photoreceptor. Besides, mutations in the Methods: Multiple ophthalmic examinations, whole-exome sequencing, sanger sequencing, and Results: Our findings revealed a novel truncating mutation c.2015_2018del p. (Lys672Argfs∗9) in Conclusions: This study broaden the range of genetic mutations associated with

Indexed as

Autosomal dominant retinitis pigmentosaChinses pedigreeIn silico analysisNovel mutationRP1 gene

Identifiers

PMID39911684
PMCPMC11795563

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.